|
Market Closed -
Other stock markets
|
Pre-market 06:12:58 | |||
| 47.05 USD | -0.32% |
|
47.99 | +2.00% |
| 07-13 | BofA Securities Adjusts 10x Genomics Price Target to $46 From $30 | MT |
| 06-29 | Roche takes aim at Illumina's dominance with new gene sequencing machine | RE |
| Market Cap | 5.97B 5.23B 4.86B 4.46B 8.41B 576B 8.54B 57.88B 22.65B 282B 22.42B 21.94B 974B | P/E 2026 * |
-58x | P/E 2027 * | -67.4x |
|---|---|---|---|---|---|
| Enterprise Value | 5.49B 4.81B 4.47B 4.11B 7.74B 530B 7.85B 53.25B 20.84B 259B 20.63B 20.18B 896B | EV / Sales 2026 * |
8.95x | EV / Sales 2027 * | 8.08x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: 10x Genomics, Inc.
| 1 day | -0.32% | ||
| 1 week | +2.84% | ||
| Current month | +22.72% | ||
| 1 month | +42.84% | ||
| 3 months | +106.09% | ||
| 6 months | +102.89% | ||
| Current year | +188.47% |
| 1 week | 41.93 |  | 47.85 |
| 1 month | 32.65 | | 47.85 |
| Current year | 15.9 | | 47.85 |
| 1 year | 11.16 | | 47.85 |
| 3 years | 6.78 | | 63.57 |
| 5 years | 6.78 | | 191.15 |
| 10 years | 6.78 | | 208.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Serge Saxonov
CEO | Chief Executive Officer | 49 | 2012-07-01 |
Ben Hindson
PSD | President | 51 | 2012-09-30 |
Adam Taich
DFI | Director of Finance/CFO | 51 | 2024-08-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Hindson
BRD | Director/Board Member | 51 | 2012-07-01 |
Serge Saxonov
BRD | Director/Board Member | 49 | 2012-07-01 |
John Stuelpnagel
CHM | Chairman | 68 | 2013-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/22/26 | Sell | Founder | -30,000 | 0.0257% | ||
| 6/16/26 | Sell | Director | -5,723 | 0.0049% | ||
| 6/4/26 | Free | Director | 8,829 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | +2.84% | +262.20% | -21.53% | 5.97B | |
| -1.01% | -7.49% | +225.95% | +300.29% | 19.99B | |
| -1.65% | -5.50% | -43.69% | -27.99% | 9.4B | |
| -3.09% | +0.28% | +44.61% | +19.50% | 6.81B | |
| +5.53% | +10.24% | -11.74% | -21.77% | 5.62B | |
| +2.37% | +21.87% | +109.07% | +134.13% | 5.06B | |
| -2.23% | -11.91% | -49.22% | - | 4.35B | |
| -0.48% | -4.44% | -26.82% | -29.08% | 4.05B | |
| +0.15% | +0.83% | -15.19% | -38.73% | 2.76B | |
| -6.33% | -11.35% | -36.49% | +202.16% | 1.6B | |
| Average | -0.71% | -1.66% | +45.87% | +57.44% | 6.56B | |
| Weighted average by Cap. | -0.56% | -2.10% | +92.02% | +104.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 614M 538M 499M 459M 865M 59.25B 878M 5.95B 2.33B 28.99B 2.31B 2.26B 100B | 671M 588M 546M 502M 946M 64.79B 960M 6.51B 2.55B 31.7B 2.52B 2.47B 110B |
| Net income | -104M -91.53M -84.98M -78.08M -147M -10.08B -149M -1.01B -396M -4.93B -392M -384M -17.04B | -90.68M -79.46M -73.76M -67.78M -128M -8.75B -130M -879M -344M -4.28B -340M -333M -14.79B |
| Net Debt | -478M -419M -389M -358M -674M -46.16B -684M -4.64B -1.81B -22.58B -1.8B -1.76B -78.02B | -548M -480M -446M -410M -772M -52.88B -783M -5.31B -2.08B -25.88B -2.06B -2.01B -89.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | US$47.05 | -0.32% | 2,822,554 |
| 26-07-21 | US$47.20 | +9.21% | 2,465,300 |
| 26-07-20 | US$43.22 | -1.19% | 2,383,841 |
| 26-07-17 | US$43.74 | -1.66% | 2,567,096 |
| 26-07-16 | US$44.48 | -2.78% | 4,717,082 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TXG Stock
Select your edition
All financial news and data tailored to specific country editions
